ArticleOncotarget2017
Retinoblastoma cells activate the AKT pathway and are vulnerable to the PI3K/mTOR inhibitor NVP-BEZ235.
Chencheng Xie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this papercites it
ArticleOncotarget2017
Chencheng Xie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.